 Intranasal amphotericin frequency invasive aspergillosis neutropenic patients PURPOSE prophylaxis invasive aspergillosis neutropenic patients frequency fungal disease causal factors PATIENTS METHODS Between patients underwent intensive treatment episodes acute leukemia lymphoma aplastic anemia frequency aspergillus infection RESULTS Proven invasive aspergillus infections cases fatal Invasive aspergillosis cases patients amphotericin treatment Colonization Aspergillus absence significant infection treatment episodes Invasive aspergillosis upper respiratory tract skin Control infection control underlying disease subsequent return normal marrow function resolution neutropenia incidence aspergillus infection due introduction intranasal amphotericin persistence aspergillus spores hematology air period CONCLUSION Intranasal invasive aspergillosis neutropenic patients conventional wards HEPA filtration